OBA Financial Services Announced Takeover Offer Of F.N.B.

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Stephen Frank

OBA Financial Services Announced Takeover Offer Of F.N.B.

ARC Group Worldwide (ARCW) Reported Acquisition of Two Companies

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Alex Hull

ARC Group Worldwide (ARCW) Reported Acquisition of Two Companies

Main Street Capital Seold 4 million shares

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Andrew Carideo

Main Street Capital Seold 4 million shares

Starwood Property (STWD) Reported Pubclic Offering of 22 million Shares

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Annie Barr

Starwood Property (STWD) Reported Pubclic Offering of 22 million Shares

Qualcomm Raises Quarterly Dividend by 20%

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Anthony Simpson

Qualcomm Raises Quarterly Dividend by 20%

Eli Lilly Lost 1% Because of the Court’s Damages Order of $3 Billion

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by David Fagan

Eli Lilly Lost 1% Because of the Court’s Damages Order of $3 Billion

PetroQuest Energy Reported First Quarter Production Guidance

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by James Lavish

PetroQuest Energy Reported First Quarter Production Guidance

CONSOL Energy Announced Positive Outlook

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Jared Haas

CONSOL Energy Announced Positive Outlook

Teva Pharmaceutical Got Food and Drug Administration Approval

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Justin Chase

Teva Pharmaceutical Got Food and Drug Administration Approval.

Eldorado Gold Gained 2.7% After Announcing Its New Project

April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Lauren Reece

Eldorado Gold Gained 2.7% After Announcing Its New Project